University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Differences in the prevalence of ankylosing spondylitis in primary and secondary care : only one-third of patients are managed in rheumatology

Simple item page
dc.contributor.authorDean, Linda E.
dc.contributor.authorMacfarlane, Gary J.
dc.contributor.authorJones, Gareth T.
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Epidemiology Groupen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2017-06-27T23:03:22Z
dc.date.available2017-06-27T23:03:22Z
dc.date.embargoedUntil2017-06-27
dc.date.issued2016-10
dc.descriptionWe would like to thank all the clinicians and research nurses who facilitated recruitment and data collection. In particular we would like to thank the SIRAS steering committee, especially Prof Roger Sturrock (chair) and Dr David Marshall (vice chair). We would also like to thank the SIRAS coordinating centre study team, in particular Elizabeth Jones, Giles O’Donovan, Nabi Moaven-Hashemi and Flora Joyce. We would like to thank the PCCIUR research group for providing data, in particular Dr Chris Burton, Dr Margaret Watson, Dr Karen Lefevre, Katie Wilde and Nathan Staudt. All authors jointly conceived of the idea of the study. G.T.J. managed the day-to-day running of the study and data collection. G.J.M. was chief investigator of the SIRAS study and was involved in overseeing the analysis. L.E.D. conducted the analysis, under the supervision of G.T.J., and produced the first draft of the article. G.J.M. and G.T.J. provided critical comments and revisions to the final manuscript. SIRAS was funded by unrestricted grants from Pfizer and AbbVie. L.E.D. conducted the analysis for this study while being partly funded by a Medical Research Council Doctoral Training Grant. Funding: No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.en
dc.description.statusPeer revieweden
dc.format.extent6
dc.format.extent45840
dc.identifier66993644
dc.identifierfdc9e573-4377-4161-8866-d1e462b744de
dc.identifier84991096951
dc.identifier.citationDean, L E, Macfarlane, G J & Jones, G T 2016, 'Differences in the prevalence of ankylosing spondylitis in primary and secondary care : only one-third of patients are managed in rheumatology', Rheumatology, vol. 55, no. 10, pp. 1820-1825. https://doi.org/10.1093/rheumatology/kew228en
dc.identifier.doi10.1093/rheumatology/kew228
dc.identifier.iss10en
dc.identifier.issn1462-0324
dc.identifier.otherORCID: /0000-0003-2322-3314/work/29064656
dc.identifier.otherORCID: /0000-0003-0016-7591/work/83703997
dc.identifier.urihttp://hdl.handle.net/2164/8882
dc.identifier.vol55en
dc.language.isoeng
dc.relation.ispartofRheumatologyen
dc.subjectankylosing spondylitisen
dc.subjectspondyloarthritisen
dc.subjectprevalenceen
dc.subjectepidemiologyen
dc.subjectR Medicineen
dc.subjectMedical Research Council (MRC)en
dc.subject.lccRen
dc.titleDifferences in the prevalence of ankylosing spondylitis in primary and secondary care : only one-third of patients are managed in rheumatologyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
SIRAS_PICCUR_prevalence_clean_.docx
Size:
44.77 KB
Format:
Unknown data format
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.29 KB
Format:
Plain Text
Description:
Download

Collections

All research
Applied Health Sciences research
University Office research